CBU
ADMA icon

CIBC Bancorp USA’s ADMA Biologics ADMA Stock Holding History

CIBC Bancorp USA’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$179K Buy
21,426
+1,101
+5% +$10K ﹤0.01% 1797
2026
Q1 		$183K Buy
+20,325
New +$321K ﹤0.01% 1629
2025
Q3 		$362K Buy
+24,714
New +$424K ﹤0.01% 1003

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

CIBC Bancorp USA's ADMA Position: Q2 2026 in Review

CIBC Bancorp USA increased its ADMA Biologics (ADMA) stake by 5.4% in Q2 2026, buying an estimated $10K and bringing the position to 21,426 shares worth $179K. The position accounts for ﹤0.01% of the portfolio, ranked #1797.

CIBC Bancorp USA first reported a position in ADMA in Q3 2025 and has held it in 3 quarters since. The position peaked at $362K in Q3 2025. 302 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • CIBC Bancorp USA held 21,426 shares of ADMA Biologics worth $179K as of Q2 2026.
  • CIBC Bancorp USA bought 1,101 ADMA Biologics shares in Q2 2026, an estimated $10K.
  • ADMA Biologics made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1797 holding.
  • CIBC Bancorp USA first reported a position in ADMA Biologics in Q3 2025 and has held it in 3 quarters since.
  • CIBC Bancorp USA's ADMA Biologics position peaked at $362K in Q3 2025.
  • 302 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.